Search research articles
Contact Us
Filters
Showing results (361-370 of 420) with videos related to
Page
of 42
Sort By:
Psycho-Oncology
|
March 19, 2021
Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy
Anna Barata, Aasha I Hoogland, Kelly A Hyland, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Transplantation and Cellular Therapy
|
July 30, 2021
Increased Infections and Delayed CD4<sup>+</sup> T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation
Farhad Khimani, Peter Ranspach, Hany Elmariah, et al.
Sports Medicine (Auckland, N.Z.)
|
July 12, 2024
Sex Differences Across Concussion Characteristics in US Service Academy Cadets: A CARE Consortium Study
Louise A Kelly, J B Caccese, D Jain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial
Matthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Transplantation and Cellular Therapy
|
May 13, 2024
Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma
Yumeng Zhang, Ashley Rose, Sushmita Khadka, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
The Journal of Clinical Investigation
|
January 31, 2023
Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models
Xu Han, Yang Mei, Rama K Mishra, et al.
Transplantation and Cellular Therapy
|
May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells
Viktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
Cancer Cell
|
November 5, 2019
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han, Atul D Jain, Mihai I Truica, et al.
Page
of 42
Search research articles
Search
Showing results (361-370 of 420) with videos related to
Sort By:
Page
of 42
Psycho-Oncology
|
March 19, 2021
Quality of life in caregivers of patients receiving chimeric antigen receptor T-cell therapy
Anna Barata, Aasha I Hoogland, Kelly A Hyland, et al.
International Journal of Molecular Sciences
|
May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) Therapy
Sepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Transplantation and Cellular Therapy
|
July 30, 2021
Increased Infections and Delayed CD4<sup>+</sup> T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation
Farhad Khimani, Peter Ranspach, Hany Elmariah, et al.
Sports Medicine (Auckland, N.Z.)
|
July 12, 2024
Sex Differences Across Concussion Characteristics in US Service Academy Cadets: A CARE Consortium Study
Louise A Kelly, J B Caccese, D Jain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2021
Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial
Matthew J Frank, Nasheed M Hossain, Ali Bukhari, et al.
Transplantation and Cellular Therapy
|
May 13, 2024
Autologous Hematopoietic Cell Transplantation Consolidation for First Response is Associated With Longer Survival Among Patients With Nodal Peripheral T Cell Lymphoma
Yumeng Zhang, Ashley Rose, Sushmita Khadka, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2026
A circulating protein signature for predicting severe immune-related adverse events following CAR T-cell therapy in relapsed/refractory lymphoma
Ehsan Irajizad, Johannes F Fahrmann, Hiroyuki Katayama, et al.
The Journal of Clinical Investigation
|
January 31, 2023
Targeting pleckstrin-2/Akt signaling reduces proliferation in myeloproliferative neoplasm models
Xu Han, Yang Mei, Rama K Mishra, et al.
Transplantation and Cellular Therapy
|
May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells
Viktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
Cancer Cell
|
November 5, 2019
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy
Huiying Han, Atul D Jain, Mihai I Truica, et al.
Page
of 42